Stock listing
HKEX:6922 Cryofocus Medtech (Shanghai) Co. Ltd. (康灃生物) 股價
Follow Cryofocus Medtech (Shanghai) Co. Ltd. into a list and get an email when it puts out news.
Share price · HKEX:6922
$2.00 HKD 0.00 (0.0%)
Close on Nov 20, 2026
- Day range
- $2.00 – $2.00 HKDNov 20, 2026
- Volume
- 8,600 sharesNov 20, 2026
- Market cap
- $297.3M HKDAt the close on Nov 20, 2026 · price × 149.0M shares outstanding
- 52-week range
- $1.84 – $7.00 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $119,280 HKDMedian day 43,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:6922 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.995 | 0.00 | 0.0% | $1.995 | $1.995 | $1.995 | 8,600 | |
| $1.995 | +0.155 | +8.4% | $1.90 | $1.995 | $1.90 | 9,400 | |
| $1.84 | -0.155 | -7.8% | $1.84 | $1.84 | $1.84 | 5,000 | |
| $1.995 | -0.005 | -0.2% | $1.995 | $1.995 | $1.995 | 1,600 | |
| $2.00 | +0.01 | +0.5% | $1.995 | $2.00 | $1.995 | 4,800 | |
| $1.99 | -0.005 | -0.3% | $1.995 | $1.995 | $1.99 | 3,000 | |
| $1.995 | +0.015 | +0.8% | $1.975 | $1.995 | $1.975 | 8,800 | |
| $1.98 | -0.005 | -0.3% | $1.90 | $1.985 | $1.90 | 5,800 | |
| $1.985 | -0.05 | -2.5% | $1.90 | $1.985 | $1.90 | 37,200 | |
| $2.035 | 0.00 | 0.0% | $2.035 | $2.035 | $2.035 | 2,400 | |
| $2.035 | +0.01 | +0.5% | $2.025 | $2.085 | $2.01 | 80,600 | |
| $2.025 | -0.02 | -1.0% | $2.045 | $2.045 | $2.00 | 59,400 | |
| $2.045 | +0.065 | +3.3% | $1.98 | $2.20 | $1.955 | 100,600 | |
| $1.98 | +0.05 | +2.6% | $1.94 | $2.00 | $1.91 | 98,800 | |
| $1.93 | -0.07 | -3.5% | $2.00 | $2.00 | $1.90 | 61,600 | |
| $2.00 | -0.245 | -10.9% | $2.19 | $2.19 | $1.92 | 59,200 | |
| $2.245 | -0.045 | -2.0% | $2.27 | $2.28 | $2.21 | 49,400 | |
| $2.29 | -0.035 | -1.5% | $2.32 | $2.32 | $2.075 | 49,400 | |
| $2.325 | -0.065 | -2.7% | $2.35 | $2.445 | $2.24 | 52,600 | |
| $2.39 | +0.01 | +0.4% | $2.40 | $2.435 | $2.35 | 84,800 | |
| $2.38 | -0.39 | -14.1% | $2.685 | $2.685 | $2.35 | 50,400 | |
| $2.77 | -0.055 | -1.9% | $2.815 | $2.815 | $2.75 | 51,800 | |
| $2.825 | -0.125 | -4.2% | $2.95 | $2.95 | $2.595 | 46,200 | |
| $2.95 | -0.035 | -1.2% | $2.98 | $2.98 | $2.95 | 41,000 | |
| $2.985 | +0.005 | +0.2% | $2.98 | $3.03 | $2.96 | 65,600 | |
| $2.98 | -0.02 | -0.7% | $2.995 | $2.995 | $2.98 | 59,200 | |
| $3.00 | -0.015 | -0.5% | $3.01 | $3.01 | $3.00 | 41,000 | |
| $3.015 | +0.025 | +0.8% | $3.00 | $3.03 | $3.00 | 43,600 | |
| $2.99 | -0.01 | -0.3% | $2.995 | $2.995 | $2.955 | 49,600 | |
| $3.00 | -0.02 | -0.7% | $3.01 | $3.015 | $2.995 | 41,200 | |
| $3.02 | 0.00 | 0.0% | $3.015 | $3.02 | $3.01 | 41,400 | |
| $3.02 | -0.005 | -0.2% | $3.02 | $3.02 | $3.01 | 41,000 | |
| $3.025 | -0.005 | -0.2% | $3.03 | $3.03 | $3.02 | 41,000 | |
| $3.03 | 0.00 | 0.0% | $3.03 | $3.03 | $3.02 | 41,000 | |
| $3.03 | -0.005 | -0.2% | $3.03 | $3.03 | $3.03 | 46,400 | |
| $3.035 | -0.005 | -0.2% | $3.04 | $3.04 | $3.02 | 44,600 | |
| $3.04 | +0.03 | +1.0% | $3.01 | $3.10 | $3.00 | 67,600 | |
| $3.01 | +0.16 | +5.6% | $2.85 | $3.01 | $2.85 | 73,800 | |
| $2.85 | +0.285 | +11.1% | $2.565 | $2.87 | $2.565 | 73,800 | |
| $2.565 | -0.005 | -0.2% | $2.565 | $2.565 | $2.565 | 41,000 | |
| $2.57 | -0.015 | -0.6% | $2.575 | $2.575 | $2.565 | 51,200 | |
| $2.585 | -0.10 | -3.7% | $2.42 | $2.595 | $2.42 | 46,000 | |
| $2.685 | +0.19 | +7.6% | $2.495 | $2.72 | $2.495 | 79,400 | |
| $2.495 | -0.05 | -2.0% | $2.55 | $2.55 | $2.45 | 47,200 | |
| $2.545 | -0.155 | -5.7% | $2.56 | $2.645 | $2.50 | 44,800 | |
| $2.70 | +0.055 | +2.1% | $2.60 | $2.76 | $2.60 | 75,800 | |
| $2.645 | -0.02 | -0.8% | $2.66 | $2.66 | $2.645 | 41,000 | |
| $2.665 | -0.11 | -4.0% | $2.66 | $2.665 | $2.66 | 34,800 | |
| $2.775 | -0.015 | -0.5% | $2.785 | $2.785 | $2.775 | 44,600 | |
| $2.79 | +0.13 | +4.9% | $2.66 | $2.85 | $2.66 | 78,600 | |
| $2.66 | -0.055 | -2.0% | $2.715 | $2.715 | $2.62 | 44,400 | |
| $2.715 | -0.125 | -4.4% | $2.795 | $2.795 | $2.70 | 32,800 | |
| $2.84 | -0.08 | -2.7% | $2.92 | $2.92 | $2.75 | 45,200 | |
| $2.92 | +0.015 | +0.5% | $2.85 | $2.92 | $2.70 | 42,200 | |
| $2.905 | -0.07 | -2.4% | $2.98 | $2.99 | $2.85 | 41,000 | |
| $2.975 | -0.025 | -0.8% | $3.00 | $3.00 | $2.895 | 39,000 | |
| $3.00 | -0.055 | -1.8% | $3.00 | $3.005 | $3.00 | 21,200 | |
| $3.055 | -0.195 | -6.0% | $3.195 | $3.195 | $3.00 | 38,200 | |
| $3.25 | -0.015 | -0.5% | $3.27 | $3.27 | $3.05 | 40,800 | |
| $3.265 | -0.035 | -1.1% | $3.40 | $3.40 | $3.26 | 33,400 | |
| $3.30 | -0.065 | -1.9% | $3.36 | $3.36 | $3.30 | 28,600 | |
| $3.365 | -0.04 | -1.2% | $3.395 | $3.395 | $3.32 | 43,200 | |
| $3.405 | -0.05 | -1.4% | $3.445 | $3.445 | $3.40 | 38,000 | |
| $3.455 | -0.06 | -1.7% | $3.45 | $3.47 | $3.415 | 38,000 |
- Ticker
- HKEX:6922
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026
Nov 4, 2026
Closed $2.04 (+0.5%) on Nov 5, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
Oct 2, 2026
Closed $3.03 (-0.2%) on Oct 5, 2026
Interim report 2026
Sep 24, 2026
Closed $3.01 (+5.6%) on Sep 25, 2026
Cryofocus Medtech (Shanghai) To Allot & Issue 7.5 Million H Shares
Jan 12, 2026
Closed $6.56 (+0.6%) on Jan 13, 2026
Cryofocus Medtech (Shanghai) Says Anti-Gastroesophageal Reflux System Granted Approval By Nmpa
Dec 16, 2025
Closed $5.97 (-1.0%) on Dec 17, 2025
Cryofocus Medtech (Shanghai) Co. Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 5 in the last 12 months · 5 in all · newest Nov 4, 2026 · oldest 2025
Valuation
EV/sales 2.0× against a median of 1.3×: 8th lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $227.6M HKD
- P/E
- Loss
- EV/sales
- 2.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 3.8×
- Gross margin
- 67.2%
- Operating margin
- −44.6%
- Net margin
- −40.1%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cryofocus Medtech (Shanghai) Co. Ltd. Class H · HKEX:6922 | US$37.93M | US$29.03M | n/a | 2.0× | n/a | 3.8× | −40.1% | 0.0× | n/a |
| electroCore, Inc. · NASDAQ:ECOR | US$40.78M | US$41.51M | n/a | 1.1× | n/a | n/a | −33.5% | n/a | 1.91 |
| Elutia, Inc. · NASDAQ:ELUT | US$39.86M | US$18.87M | 0.7× | 1.5× | n/a | 2.6× | 441.2% | 0.5× | -0.06 |
| DRGEM Corp. · KRX:263690 | US$38.81M | US$32.33M | 4.3× | 0.4× | 3.2× | 0.5× | 11.2% | 0.1× | n/a |
| Ocumetics Technology Corp · TSXV:OTC | US$37.38M | US$37.60M | n/a | n/a | n/a | n/a | n/a | n/a | 0.14 |
| Optomed Oyj Class A · OMXHEX:OPTOMED | US$37.24M | US$32.48M | n/a | 1.8× | n/a | 1.6× | −33.9% | 0.1× | n/a |
| Sensus Healthcare, Inc. · NASDAQ:SRTS | US$37.20M | US$24.56M | n/a | 1.5× | n/a | 1.1× | −96.5% | 0.0× | 1.08 |
| Epiminder Ltd. · ASX:EPI | US$36.57M | −US$13.60M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | n/a |
| Avita Corporation · TPEX:4735 | US$35.63M | US$14.80M | 5.1× | 0.5× | 4.4× | 1.0× | 23.8% | 0.0× | n/a |
| SELVAS Healthcare, Inc. · KRX:208370 | US$35.56M | US$15.07M | 5.5× | 0.6× | 8.0× | 0.6× | 27.5% | 0.0× | n/a |
| Taiwan Biomaterial Co., Ltd. · TPEX:6649 | US$35.55M | US$28.06M | 35.3× | 5.1× | 26.5× | 1.8× | 18.2% | 0.0× | n/a |
| Median of the others | US$37.22M | US$26.31M | 5.1× | 1.3× | 6.2× | 1.1× | 14.7% | 0.0× | 0.61 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Sep 22, 2025 | −4.8% |
| Quarter to Mar 31, 2025 | Apr 29, 2025 | +12.9% |
| Q4 2024 | Mar 31, 2025 | +7.9% |
Financials
Annual, in CNY
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 95.3M | 53.5M | 41.0M | 27.1M | 22.4M | 9.05M |
| Cost of revenue | 31.3M | 15.1M | 9.90M | 7.79M | 6.88M | 4.41M |
| Gross profit | 64.0M | 38.4M | 31.1M | 19.4M | 15.5M | 4.64M |
| Research and development | 30.4M | 73.5M | 76.1M | 59.9M | 89.8M | 42.3M |
| Selling, general and administrative | 77.0M | 95.3M | 74.7M | 88.3M | 55.6M | 126.9M |
| Operating income | -42.5M | -110.1M | -105.1M | -117.7M | -126.1M | -159.3M |
| Depreciation and amortization | 9.26M | 11.8M | 9.41M | 7.62M | 4.46M | 3.15M |
| EBITDA | -33.2M | -98.2M | -95.7M | -110.1M | -121.7M | -156.1M |
| Interest expense | 1.95M | 1.16M | 1.70M | 3.08M | 2.70M | 1.56M |
| Income before tax | -44.5M | -111.1M | -105.7M | -118.3M | -126.5M | -159.3M |
| Net income | -38.2M | -104.4M | -97.5M | -112.2M | -101.9M | -137.1M |
| Earnings per share, basic | -0.16 | -0.44 | -0.41 | -0.47 | -0.43 | -0.57 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 35.0M | 45.5M | 103.4M | 226.4M | 157.9M | 7.49M |
| Short-term investments | 0 | 25.5M | ||||
| Receivables | 0 | 0 | 0 | 0 | 0 | |
| Inventory | 32.9M | 29.9M | 24.4M | 19.9M | 20.9M | 17.0M |
| Current assets | 91.2M | 98.2M | 149.9M | 264.2M | 189.4M | 51.0M |
| Property, plant and equipment | 31.3M | 38.6M | 51.3M | 41.8M | 38.1M | 20.1M |
| Total assets | 137.5M | 149.2M | 212.8M | 313.9M | 231.7M | 74.4M |
| Accounts payable | 2.49M | 1.21M | 906.0K | 1.76M | 314.0K | 185.0K |
| Current liabilities | 60.2M | 59.8M | 30.8M | 45.7M | 28.3M | 23.5M |
| Total liabilities | 87.7M | 75.4M | 51.4M | 74.7M | 61.0M | 24.1M |
| Shareholders' equity | 49.7M | 73.8M | 161.5M | 239.1M | 170.6M | 50.3M |
| Shares outstanding | 239.1M | 239.1M | 239.1M | 239.1M | 239.1M | 239.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -5.82M | -82.9M | -95.9M | -96.9M | -62.5M | -34.2M |
| Capital spending | -770.0K | -1.88M | -15.1M | -7.01M | -12.5M | -1.51M |
| Free cash flow | -6.59M | -84.8M | -111.0M | -103.9M | -75.0M | -35.7M |
| Cash from investing | -1.88M | -15.1M | -6.55M | 15.7M | 27.0M | |
| Cash from financing | 25.5M | -13.7M | 169.4M | 197.7M | -608.0K | |
| Share buybacks | 0 | 187.5M | 204.4M | 0 | ||
| Change in cash | -9.85M | -57.9M | -123.0M | 68.6M | 150.4M | -7.89M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2026 | Nov 4, 2026 | Monthly return | HKEX |
| Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026 | Oct 2, 2026 | Monthly return | HKEX |
| INTERIM REPORT 2026 | Sep 24, 2026 | Interim report | HKEX |
Cap table
Built by 6ix from Cryofocus Medtech (Shanghai) Co. Ltd. Class H’s releases
- Common shares
- 149,033,579
- Fully diluted
- 149,033,579
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 149,033,579 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 149,033,579 |
Log in to ask 6ix AI your own questions about Cryofocus Medtech (Shanghai) Co. Ltd.